EPISODE · Oct 22, 2021 · 38 MIN
Michael Hill, Former Vice President, Science & Technology and Innovation at Medtronic
from Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere · host Julio G. Martinez-Clark
Dr. Michael Hill is a global-minded senior executive with a history of success creating meaningful, patient-inspired, medical device technology innovations. He is a skilled entrepreneur demonstrating repeat innovation execution from idea/discovery to commercial scale. He was inducted in 2012 as an American Institute of Medical and Biological Engineering Fellow and awarded the Distinguished Engineering Alumni from Duke University in 2013. He possesses deep domain knowledge of science and technology and has more than 27 years of experience with research, product development, and clinical research/regulatory. He is adept in successfully leading large global organizations, as well as multiple programs and projects, to achieve target goals. He has a thorough understanding of the fundamentals related to global healthcare systems to deliver impactful transformative innovations. Dr. Hill received his BSE [Biomedical and Electrical Engineering] and BS [Mathematics] Degrees from Duke University, MS, and Ph.D. [Biomedical Engineering] Degrees from Case Western Reserve University, and MBA [Management] Degree from the University of St. Thomas.
What this episode covers
Dr. Michael Hill is a global-minded senior executive with a history of success creating meaningful, patient-inspired, medical device technology innovations. He is a skilled entrepreneur demonstrating repeat innovation execution from idea/discovery to commercial scale. He was inducted in 2012 as an American Institute of Medical and Biological Engineering Fellow and awarded the Distinguished Engineering Alumni from Duke University in 2013. He possesses deep domain knowledge of science and techn...
NOW PLAYING
Michael Hill, Former Vice President, Science & Technology and Innovation at Medtronic
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m